Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.

Literature DB >> 10023900

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.

P Maddison, J Newsom-Davis, K R Mills, R L Souhami.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1999 PMID： 10023900 DOI： 10.1016/S0140-6736(05)76153-5

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

41 in total

1. Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.

Authors: Aykan A Karabudak; Julie Hafner; Vivekananda Shetty; Songming Chen; Angeles Alvarez Secord; Michael A Morse; Ramila Philip
Journal: J Cancer Res Clin Oncol Date: 2013-09-03 Impact factor: 4.553

2. Progress in the management of paraneoplastic neurological disorders.

Authors: Hamid Sadeghian; Steven Vernino
Journal: Ther Adv Neurol Disord Date: 2010-01 Impact factor: 6.570

Review 3. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.

Authors: Leora Horn; Martin Reck; David R Spigel
Journal: Oncologist Date: 2016-06-27

4. Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

Authors: M Hardy-Werbin; O Arpí; A Taus; P Rocha; D Joseph-Pietras; L Nolan; S Danson; R Griffiths; M Lopez-Botet; A Rovira; J Albanell; C H Ottensmeier; E Arriola
Journal: Oncoimmunology Date: 2017-11-27 Impact factor: 8.110

5. Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.

Authors: Wade T Iams; Eileen Shiuan; Catherine B Meador; Marc Roth; Jennifer Bordeaux; Christine Vaupel; Kelli L Boyd; IlaSri B Summitt; Lucy L Wang; Joseph T Schneider; Jeremy L Warner; Zhiguo Zhao; Christine M Lovly
Journal: J Thorac Oncol Date: 2019-06-12 Impact factor: 15.609

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.

1. Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.

2. Progress in the management of paraneoplastic neurological disorders.

Review 3. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.

4. Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

5. Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.

6. Small-cell lung cancer in the era of immunotherapy.

Review 7. Immune checkpoint inhibitors in small cell lung cancer.

Review 8. Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors.

Review 9. [Myasthenia gravis and myasthenic syndromes].

10. Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.